HeartBeam to deploy leadless AI ECG platform in Atelier Health practices
BEAT•HeartBeam has inked an agreement with concierge medicine provider Atelier Health to deploy its AI-powered, leadless ECG platform across Atelier’s concierge cardiology practices, marking its debut in the high-end at-home heart monitoring segment. The partnership targets an initial rollout covering hundreds of patients to enhance remote cardiac diagnostics.
1. Partnership Overview
HeartBeam entered a strategic agreement with Atelier Health on May 7, 2026, to integrate its leadless ECG platform into Atelier’s concierge cardiology services. The deal grants HeartBeam access to Atelier’s network of high-net-worth patients and establishes a new distribution channel in the concierge medicine market.
2. Platform Capabilities
HeartBeam’s wearable, AI-driven system captures 12-lead equivalent ECG data without external wires and transmits results in real time to Atelier’s care teams, enabling at-home monitoring and faster diagnostics. The system includes a smartphone app, clinician dashboard, and automated alert features for arrhythmias and ischemic events.
3. Market Implications
This marks HeartBeam’s first entry into the concierge cardiology segment, potentially unlocking a premium revenue stream and enhancing brand visibility among affluent patient populations. Success here could pave the way for further partnerships with private medical providers and broader commercial deployments.
